129 related articles for article (PubMed ID: 15269132)
1. The cooperative prostate cancer tissue resource: a specimen and data resource for cancer researchers.
Melamed J; Datta MW; Becich MJ; Orenstein JM; Dhir R; Silver S; Fidélia-Lambert M; Kadjacsy-Balla A; Macias V; Patel A; Walden PD; Bosland MC; Berman JJ
Clin Cancer Res; 2004 Jul; 10(14):4614-21. PubMed ID: 15269132
[TBL] [Abstract][Full Text] [Related]
2. The development of common data elements for a multi-institute prostate cancer tissue bank: the Cooperative Prostate Cancer Tissue Resource (CPCTR) experience.
Patel AA; Kajdacsy-Balla A; Berman JJ; Bosland M; Datta MW; Dhir R; Gilbertson J; Melamed J; Orenstein J; Tai KF; Becich MJ
BMC Cancer; 2005 Aug; 5():108. PubMed ID: 16111498
[TBL] [Abstract][Full Text] [Related]
3. An informatics model for tissue banks--lessons learned from the Cooperative Prostate Cancer Tissue Resource.
Patel AA; Gilbertson JR; Parwani AV; Dhir R; Datta MW; Gupta R; Berman JJ; Melamed J; Kajdacsy-Balla A; Orenstein J; Becich MJ;
BMC Cancer; 2006 May; 6():120. PubMed ID: 16677389
[TBL] [Abstract][Full Text] [Related]
4. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
[TBL] [Abstract][Full Text] [Related]
5. The tissue microarray data exchange specification: implementation by the Cooperative Prostate Cancer Tissue Resource.
Berman JJ; Datta M; Kajdacsy-Balla A; Melamed J; Orenstein J; Dobbin K; Patel A; Dhir R; Becich MJ
BMC Bioinformatics; 2004 Feb; 5():19. PubMed ID: 15040818
[TBL] [Abstract][Full Text] [Related]
6. Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometry.
Veltri RW; Miller MC; Isharwal S; Marlow C; Makarov DV; Partin AW
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):102-10. PubMed ID: 18199716
[TBL] [Abstract][Full Text] [Related]
7. Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy.
Mazzucchelli R; Barbisan F; Tagliabracci A; Lopez-Beltran A; Cheng L; Scarpelli M; Montironi R
Virchows Arch; 2007 Apr; 450(4):371-8. PubMed ID: 17285325
[TBL] [Abstract][Full Text] [Related]
8. A novel technique for biobanking of large sections of radical prostatectomy specimens.
Lindh C; Delahunt B; Samaratunga H; Yaxley J; Gudjónsdóttir J; Clements M; Lindberg J; Egevad L
Histopathology; 2018 Feb; 72(3):481-489. PubMed ID: 28881048
[TBL] [Abstract][Full Text] [Related]
9. Minimal or no residual prostatic adenocarcinoma on radical prostatectomy: a 5-year experience with "vanishing carcinoma phenomenon".
Kosarac O; Zhai QJ; Shen S; Takei H; Ro JY; Ayala AG
Arch Pathol Lab Med; 2011 Nov; 135(11):1466-70. PubMed ID: 22032574
[TBL] [Abstract][Full Text] [Related]
10. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
[TBL] [Abstract][Full Text] [Related]
11. Banking of fresh-frozen prostate tissue using the alternate mirror image protocol: methods, validation, and impact on the pathological prognostic parameters in radical prostatectomy.
Brimo F; Sircar K; Chevalier S; Saad F; Lacombe L; Têtu B; Scarlata E; Aprikian A
Cell Tissue Bank; 2012 Dec; 13(4):631-8. PubMed ID: 22200970
[TBL] [Abstract][Full Text] [Related]
12. Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer.
Bañez LL; Sun L; van Leenders GJ; Wheeler TM; Bangma CH; Freedland SJ; Ittmann MM; Lark AL; Madden JF; Hartman A; Weiss G; Castaños-Vélez E
J Urol; 2010 Jul; 184(1):149-56. PubMed ID: 20478579
[TBL] [Abstract][Full Text] [Related]
13. Obtaining fresh prostate cancer tissue for research: a novel biopsy needle and sampling technique for radical prostatectomy specimens.
Walton TJ; McCulloch TA; Rees RC; Bishop MC
Prostate; 2005 Sep; 64(4):382-6. PubMed ID: 15754345
[TBL] [Abstract][Full Text] [Related]
14. The Cooperative Breast Cancer Tissue Resource: archival tissue for the investigation of tumor markers.
Glass AG; Donis-Keller H; Mies C; Russo J; Zehnbauer B; Taube S; Aamodt R;
Clin Cancer Res; 2001 Jul; 7(7):1843-9. PubMed ID: 11448894
[TBL] [Abstract][Full Text] [Related]
15. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
[TBL] [Abstract][Full Text] [Related]
16. Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy.
Freedland SJ; deGregorio F; Sacoolidge JC; Elshimali YI; Csathy GS; Dorey F; Reiter RE; Aronson WJ
J Urol; 2003 Apr; 169(4):1325-30. PubMed ID: 12629353
[TBL] [Abstract][Full Text] [Related]
17. Clusterin as a possible predictor for biochemical recurrence of prostate cancer following radical prostatectomy with intermediate Gleason scores: a preliminary report.
Pins MR; Fiadjoe JE; Korley F; Wong M; Rademaker AW; Jovanovic B; Yoo TK; Kozlowski JM; Raji A; Yang XJ; Lee C
Prostate Cancer Prostatic Dis; 2004; 7(3):243-8. PubMed ID: 15343364
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative frozen section of the prostate decreases positive margin rate while ensuring nerve sparing procedure during radical prostatectomy.
von Bodman C; Brock M; Roghmann F; Byers A; Löppenberg B; Braun K; Pastor J; Sommerer F; Noldus J; Palisaar RJ
J Urol; 2013 Aug; 190(2):515-20. PubMed ID: 23415965
[TBL] [Abstract][Full Text] [Related]
19. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
[TBL] [Abstract][Full Text] [Related]
20. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
Moul JW; Connelly RR; Lubeck DP; Bauer JJ; Sun L; Flanders SC; Grossfeld GD; Carroll PR
J Urol; 2001 Oct; 166(4):1322-7. PubMed ID: 11547066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
